Using ubiquitin to follow the metabolic fate of a protein by Lévy, Frédéric et al.
Proc. Natl. Acad. Sci. USA
Vol. 93, pp. 4907-4912, May 1996
Biochemistry
Using ubiquitin to follow the metabolic fate of a protein
(proteolysis/pulse-chase/half-life/N-end rule/cell culture)
FRE'DE'RIC LEvy, NILS JOHNSSON*, TILLMANN RUMENAPFt, AND ALEXANDER VARSHAVSKYt
Division of Biology, California Institute of Technology, Pasadena, CA 91125
Contributed by Alexander Varshavsky, December 15, 1995
ABSTRACT We describe a method that can be used to
produce equimolar amounts of two or more specific proteins
in a cell. In this approach, termed the ubiquitin/pro-
tein/reference (UPR) technique, a reference protein and a
protein of interest are synthesized as a polyprotein separated
by a ubiquitin moiety. This tripartite fusion is cleaved, co-
translationally or nearly so, by ubiquitin-specific processing
proteases after the last residue of ubiquitin, producing
equimolar amounts of the protein of interest and the reference
protein bearing a C-terminal ubiquitin moiety. In applications
such as pulse-chase analysis, the UPR technique can compen-
sate for the scatter of immunoprecipitation yields, sample
volumes, and other sources of sample-to-sample variation. In
particular, this method allows a direct comparison of pro-
teins' metabolic stabilities from the pulse data alone. We used
UPR to examine the N-end rule (a relation between the in vivo
half-life of a protein and the identity of its N-terminal residue)
in L cells, a mouse cell line. The increased accuracy afforded
by the UPR technique underscores insufficiency of the current
"half-life" terminology, because in vivo degradation of many
proteins deyiates from first-order kinetics. We consider this
problem and discuss other applications of UPR.
Ubiquitin (Ub) is a 76-residue protein that exists in cells either
free or covalently linked to many different proteins. Ub-
protein conjugation is involved (directly or by way of regula-
tion) in a multitude of processes, including cell growth and
division, signal transduction, DNA repair, and the transport of
substances across membranes. In many of these processes, Ub
acts through routes that involve the degradation of Ub-protein
conjugates (1, 2). The linking of Ub to other proteins involves
the formation of an isopeptide bond between the C-terminal
glycine of Ub and the s-amino group of a Lys residue in an
acceptor protein. Unlike the resulting branched Ub-protein
conjugates, which are formed posttranslationally, linear Ub
adducts are formed as the translational products of natural or
engineered Ub fusions (2, 3).
A newly formed Ub fusion such as Ub-X-f3-galactosidase
(Ub-X-f3gal) is rapidly (cotranslationally or nearly so) cleaved at
the Ub-protein junction by Ub-specific processing proteases
(UBPs) (4, 5) regardless of the identity of a residue X at the
C-terminal side of the cleavage site, proline being the single
exception (2, 6). The relation between the metabolic stability of
a resulting protein and the identity of its N-terminal residue is
called the N-end rule (2). The N-end rule pathway has been
shown to operate in the eubacterium Escherichia coli (7), in the
yeast Saccharomyces cerevisiae (8), and in ATP-supplemented
extract from rabbit reticulocytes (9). The N-end rules of these
organisms are similar but not identical (2). The degradation signal
recognized by the N-end rule pathway is called the N-degron.
This signal comprises two determinants: a destabilizing N-
terminal residue and a specific internal lysine (or lysines) of a
protein substrate (2, 8). The Lys residue is the site of formation
of a substrate-linked multi-Ub chain, whose presence is required
for the degradation of N-end rule substrates by the protea-
some-an ATP-dependent, multisubunit protease (10).
The N-end rule is organized hierarchically. In eukaryotes
such as the yeast S. cerevisiae, Asn and Gln are tertiary
destabilizing N-terminal residues in that they function through
their conversion, by a specific amidase, into the secondary
destabilizing residues Asp and Glu, whose activity requires
their conjugation, by Arg-tRNA-protein transferase (R-
transferase), to Arg, one of primary destabilizing N-terminal
residues (2, 11). The latter are bound directly by a protein
called N-recognin or E3. In S. cerevisiae, N-recognin is a
225-kDa protein (encoded by UBR1) that selects potential
N-end rule substrates by binding to their primary destabilizing
N-terminal residues, Phe, Leu, Trp, Tyr, Ile, Arg, Lys, or His
(2). The only known metazoan N-end rule, determined not in
vivo but in ATP-supplemented extract from rabbit reticulo-
cytes, differs from the yeast N-end rule (9). In particular, Cys,
which is a stabilizing residue in S. cerevisiae (8), is a secondary
destabilizing residue in reticulocytes (9).
The understanding of N-end rule's functions remains
sketchy. The N-end rule pathway has been shown to be
required for the import of peptides in S. cerevisiae (12). It is
also required for the degradation of yeast Ga, the GPAI-
encoded a subunit of the heterotrimeric G protein (13).
Sindbis virus RNA polymerase is another physiological sub-
strate of the N-end rule pathway (14).
Determination of an N-end rule entails multiple pulse-chase
assays. A pulse-chase analysis involves the labeling of nascent
proteins for a short time with a radioactive precursor ("pulse"), the
termination of labeling, and the analysis of a labeled protein of
interest at various times afterwards ("chase"), using immunopre-
cipitation and SDS/PAGE, or analogous techniques. Its advan-
tage of being direct notwithstanding, a conventional pulse-chase
assay is fraught with sources of error. For example, the immuno-
precipitation yields may vary from sample to sample; the volumes
of samples loaded on a gel mayvary as well. As a result, pulse-chase
data tend to be semiquantitative at best, lacking the means to
control these errors. Prompted in part by the necessity to improve
the procedure for determining the N-end rule, we developed a
robust and convenient "internal reference" strategy that can com-
pensate for at least some of the data scatter in a pulse-chase assay.
Described below is a modification of the original Ub fusion
design (2, 6) that can be used to produce equimolar amounts of
two (or more) specific proteins in a cell. We apply this method,
termed the ubiquitin/protein/reference (UPR) technique, to the
pulse-chase assay and illustrate the utility of UPR by determining
the N-end rule in L cells, a fibroblast-like mouse cell line.
Abbreviations: Ub, ubiquitin (or ubiquityl moiety); UPR, ubiquitin/
protein/reference; UBP, ubiquitin-specific processing protease; ,Bgal,
E. coli j3-galactosidase; DHFR, dihydrofolate reductase; ID, initial
decay; SD, subsequent decay.
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MATERIALS AND METHODS
Construction of Plasmids. Details are available upon re-
quest. A set of ORFs encoding Ub-X-nsP4 was described (15)
(see also Results). The nsP4-coding sequence (14) was short-
ened to encode the first 165 residues of nsP4, and the resulting
fragment was ligated, in-frame, to E. coli lacZ encoding ,Bgal
that lacked the first six residues. The XbaI-StuI fragment
encoding Ub-X-nsP4165-f3gal (the nsP4165 portion of this and
related constructs is denoted below as nsP4) was blunted with
the Klenow fragment of DNA polymerase I and inserted into
the blunted Hindlll site of the pRC/CMV vector (Invitrogen),
yielding the plasmids pRC/UbXnsP4f3gal that differed at
codons encoding the residue X of Ub-X-nsP4-,Bgal. An XbaI-
Sacll fragment encoding dihydrofolate reductase (DHFR)-
ha-UbR48 was constructed by a multistep PCR. This fragment
was inserted into XbaI-SacII-cut pRc/UbXnsP4,Bgal plasmids,
yielding the plasmids pRc/dhaUbX,Bgal that expressed
DHFR-ha-UbR48-X-nsP4-pgal (dha-Ub-X-,3gal) test proteins
from the PcMv promoter (16).
Cell Culture, Transfection, and Pulse-Chase Analysis. L
cells (ATCC CCL 1.3), a line of transformed, fibroblast-like
mouse cells, were grown as monolayers in the DMEM/F12
medium (GIBCO) supplemented with 10% fetal bovine se-
rum, antibiotics, 2 mM L-glutamine, and 20 mM NaHepes (pH
7.3). The plasmids pRc/dhaUbX,Bgal were introduced into L
cells using Lipofectamine (GIBCO) and the manufacturer-
supplied protocol. After 16 hr at 37°C, a DNA-containing
solution in each 3.5-cm plate was replaced by 1 ml of serum-
free medium lacking methionine and cysteine and, after 30
min, by 0.5 ml of serum-free medium containing 0.1 mCi (1 Ci
= 37 GBq) of 35S-Express (New England Nuclear), followed by
incubation for 10 min at 37°C. Immediately thereafter, the
plates were washed with 1 ml of complete medium, the
"time-zero" plate was processed as described below, and 1 ml
of the chase medium (complete medium plus cycloheximide at
0.1 mg/ml) was added to each of the other plates. At each time
point, the chase medium was aspirated, 1 ml of ice-cold buffer
A (1% Triton X-100/0.15 M NaCl/5 mM EDTA/0.2 mg/ml
phenylmethylsulfonyl fluoride/20 mM Tris HCl, pH 7.5) was
added, and the plate was placed on ice. The lysates were
collected and centrifuged at 12,000 x g for 1 min. The volumes
of supernatants were adjusted to contain equal amounts of
10% trichloroacetic acid-insoluble 35S, followed by immuno-
precipitation with a mixture of saturating amounts of mono-
clonal antibodies against the ha epitope (Babco, Emeryville,
CA) and ,Bgal (Promega). The samples were incubated, with
rotary shaking, at 4°C for 30 min, followed by the addition of
Protein A-Sepharose (Repligen) and another 30-min incuba-
tion at 4°C. The immunoprecipitates were washed three times
in buffer A plus 0.1% SDS, resuspended in 20 ,ul of SDS-
sample buffer (16), and heated at 100°C for 3 min. The samples
were subjected to SDS/12% PAGE (16), followed by autora-
diography with x-ray films and, independently, quantitation
using a Phosphorlmager (Molecular Dynamics).
RESULTS
The UPR Technique. The strategy of UPR is illustrated in Fig.
LA. Previous work (6, 8) has shown that Ub fusions containing a
sterically accessible Ub moiety and expressed at moderate levels
are cleaved rapidly enough for the amounts of uncleaved fusion to
be negligible even at pulse times comparable with the time re-
quired for the fusion's translation (6, 8). Another study (17) ex-
plored kinetic aspects of protein transport across membranes by
using fusions that bore a signal sequence and a Ub moiety em-
bedded between two other protein domains. Fusions of this design
that could not be cotranslationally translocated into the endoplas-
mic reticulum were cleaved at the Ub-protein junction in the cyto-
sol, indicating that the presence of an N-terminal extension in the
fusion's Ub moiety did not interfere with the fusion's cleavage (17).
A Ubp
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ubiquitin-specific
proteases (UBPs)
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FIG. 1. The UPR technique. (A) A tripartite fusion containing A,
a reference protein moiety whose C-terminus is linked, via a spacer
peptide, to a Ub moiety. The C-terminus of Ub is linked to B, a protein
of interest. In vivo, this tripartite fusion is cleaved, cotranslationally or
nearly so, by UBPs at the Ub-B junction, yielding equimolar amounts
of the unmodified protein B and the reference protein A bearing a
C-terminal Ub moiety. If protein A-Ub is long-lived, determining the
ratio of A-Ub to B as a function of time or at steady state yields,
respectively, the in vivo decay curve or the relative metabolic stability
of protein B. (B) In UPR assays of the present work, the reference
protein was mouse DHFR, linked, via a 20-residue spacer containing
the ha epitope (16), to the Ub moiety bearing arginine instead of
wild-type lysine at position 48. The UbR48 moiety was fused to the test
protein, a modified E. coli j3gal bearing a varied residue (X) at the
Ub-f3gal junction, and a 165-residue insert, derived from the Sindbis
virus nsP4 protein, between X and ,Bgal (see Results). The resulting
fusion is denoted as DHFR-ha-UbR48-X-nsP4-pgal or, briefly, as
dha-Ub-X-,Bgal.
Thus, by expressing a fusion whose Ub moiety is located
between polypeptides A and B, it should be possible to
produce, cotranslationally or nearly so, equimolar amounts of
two separate polypeptides, A-Ub and B (Fig. 1A). One appli-
cation of this approach, termed the UPR technique, is to
employ A-Ub as a reference protein in a pulse-chase assay,
with B as a test protein.
UPR and the N-End Rule. The development of the UPR
technique was prompted in part by insufficient reproducibility
of conventional pulse-chase assays in studies of the N-end rule
(see the Introduction), and also by the necessity of estimating
the degradation of N-end rule substrates and other short-lived
proteins during the pulse (see below). The utility of UPR was
tested by using it to determine the N-end rule in L cells, a
fibroblast-like mouse cell line.
A UPR-based protein fusion used to determine the N-end
rule in mammalian cells comprised, starting from the N-
terminus: the 21-kDa mouse DHFR moiety; a 20-residue
linker containing the ha epitope (recognized by a monoclonal
antibody); a modified Ub moiety (UbR48) in which lysine at
position 48 had been replaced by arginine; a variable residue
X after the last residue of UbR48; and the 116-kDa E. coli ,Bgal
that lacked the first six residues of wild-type ,3gal and bore a
165-residue N-terminal extension derived from nsP4, the
Sindbis virus RNA polymerase. The entire fusion, DHFR-ha-
UbR48-X-nsP4-,3gal, is denoted below as dha-Ub-X-,3gal (Fig.
1B). The in vivo cleavage of this fusion produced dha-Ub
(DHFR-ha-UbR48), which served as a reference protein, and
X-,3gal (X-nsP4-3gal), which served as a test N-end rule
substrate, X being the variable N-terminal residue (Fig. 1B).
The use of UbR48 instead ofwild-type Ub in dha-Ub-X-,Bgal was
expected to preclude the possibility of C-terminal Ub moiety in
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dha-Ub acting as a ubiquitylation§/degradation signal [Lys-48 of
Ub is one major site of the Ub-Ub isopeptide bonds within a
multi-Ub chain, whereas an Arg residue cannot be ubiquitylated
(1)]. The 165-residue nsP4 insert corresponds to the N-terminal
region of the 70-kDa nsP4 (Sindbis virus RNA polymerase), one
physiological substrate of the N-end rule pathway (14). The func-
tion of the nsP4-derived insert in X-nsP4-,Bgal (X-3gal) was to
provide the second (intemal-lysine) determinant of the N-degron.
The previously used lysine-bearing insert in X-,Bgal was a 45-
residue sequence derived from E. coli Lac repressor (8). This insert
functions well in yeast (6, 8) but was ineffective in mammalian cells
(data not shown). We do not understand the cause of this
difference in the relative strength of a given N-degron between
yeast and mammalian cells.
Data Scatter and Its Correction by UPR. Mouse L cells were
transiently transfected with plasmids expressing dha-Ub-Met-
f3gal or dha-Ub-Arg-,3gal (Fig. 1B). The cells were labeled for
10 min at 37°C with [35S]methionine/cysteine, followed by the
addition of cycloheximide (to inhibit translation) and a chase
of 60 and 120 min. Each sample was processed for immuno-
precipitation and SDS/PAGE using a mixture of anti-ha and
anti-,Bgal antibodies (Fig. 2). In one such experiment, the
amount of 35S in Met-,Bgal at 60 min of chase was 60% of the
amount at time 0 (at the end of the 10-min pulse) (Fig. 2 A,
lanes a-c, and B, open circles), consistent with the possibility
that a large fraction of labeled Met-,3gal was degraded during
the 60-min chase. However, when the amount of 35S in
Met-f3gal was normalized against the amount of 35S in the
reference protein dha-Ub of the same sample, and the result-
ing ratios were plotted as percentages of the ratio at time 0
(Fig. 2B, closed circles), it became clear that the relative
amount of pulse-labeled Met-f3gal was in fact nearly constant
during the chase, in agreement with earlier evidence that
methionine is a stabilizing residue in the N-end rule (2, 8, 9).
The amount of 35S in Arg-,Bgal, whose N-terminal arginine is
a destabilizing residue in all of the known N-end rules (9), at time
0 was only 11% of the amount of 35S in Met-,Bgal (Fig. 2A, lane
d vs. lane a, and B, open triangles vs. open circles). The amount
of 35S in Arg-,3gal continued to decrease during the chase (Fig. 2
A, lanes d-f, and B, open triangles). These "raw" values for the
amounts of 35S in Arg-,3gal were normalized against the amount
of 35S in the reference protein dha-Ub of the same samples, and
the corresponding ratios were plotted as percentages of the
analogous ratio for Met-I3gal at time 0. Both the shape and the
initial (time-zero) values of the resulting decay curve for Arg-,Bgal
differed significantly from those of the uncorrected curve (Fig.
2B). The much lower amount of 35S in Arg-j3gal than in Met-pgal
at time 0 (Fig. 2B) resulted from extensive degradation of
Arg-4gal during the 10-min pulse (see below).
The N-End Rule in Mouse L-Cells. The pulse-chase assays
of Fig. 2 were expanded to include 19 plasmids expressing
UPR-based dha-Ub-X-f3gal (DHFR-ha-UbR48-X-nsP4-pgal)
fusions, X being a variable residue (Fig. 1B). Pro was the only
N-terminal residue absent from the set of resulting X-fgal test
proteins, because a Ub-Pro-bearing fusion is deubiquitylated
slowly in either yeast or mammalian cells (6, 9). Depending on
the identity of X in X-f3gal proteins, these proteins were either
long-lived or metabolically unstable (Fig. 3). These measure-
ments, carried out with 19 X-f3gals, yielded the N-end rule in
mouse L cells (Figs. 3 and 4, and Table 1).
As noted earlier (6, 18), the in vivo decay curves of pulse-
labeled, short-lived X-,Bgals deviated from first-order kinetics,
in that the metabolic stability of older X-,Bgal molecules was
§To bring ubiquitin-related terms in line with the standard chemical
terminology, ubiquitin whose C-terminal (Gly-76) carboxyl group is
covalently linked to another compound will be called the ubiquityl moiety,
with the derivative terms being ubiquitylation and ubiquitylated instead
of the earlier terms "ubiquitination" and "ubiquitinated" (1-3). The
abbreviation Ub will refer to both free ubiquitin and the ubiquityl moiety.
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FIG. 2. The use of UPR to compensate for data scatter in a
pulse-chase assay. (A) Mouse L cells were transfected with plasmids
expressing dha-Ub-X-13gal, the residue X being methionine or argi-
nine. Cells were labeled for 10 min with [35S]methionine/cysteine and
chased for 0 (lanes a and d), 60 (lanes b and e), and 120 min (lanes c
and f), followed by preparation of extracts, immunoprecipitation with
anti-ha and anti-,3gal antibodies, SDS/PAGE, and autoradiography
(see Materials and Methods). The bands of X-,Bgal (test proteins) and
dha-Ub (reference protein) are indicated on the left. (B) The pattern
in A was quantified using a Phosphorlmager. 0, 7, the amount of 35S
in, respectively, Met-,3gal and Arg-I3gal during the chase, plotted as a
percentage of the amount of 35S in Met-,3gal at time 0 (at the end of
pulse). 0, at each time point, the ratio of 35S in Met-I3gal to 35S in
dha-Ub was determined, and was plotted as a percentage of this ratio
at time 0. v, the same as 0 but for Arg-f3gal, with the resulting ratios
plotted as percentages of the Met-fBgal/dha-Ub ratio at time 0.
higher than the metabolic stability of their younger counter-
parts (Fig. 3). For example, the degradation of a short-lived
X-,Bgal was in all cases more rapid during the first 60 min of
chase than during the next 60 min (Fig. 3). (Control experi-
ments have shown that the kinetics of X-,3gal degradation was
not influenced significantly by the presence of cycloheximide
during the chase.) Analysis of X-3gal decay using the chase
times of 15, 30, and 60 min (Fig. 3D) instead of 60 and 120 min
(Fig. 3 A-C) indicated that the degradation of pulse-labeled
X-,3gals was strongly diminished by 15 min of chase (Fig. 3D).
Another distinct feature of the decay curves was that the relative
amount of 35S in a short-lived X-,3gal at time 0 (the end of the
10-min pulse) was always lower than the time-zero amount of 35S
in a long-lived X-,Bgal such as Met-f3gal (Fig. 3). Low yields of
short-lived X-,Bgals at time 0 were caused by their degradation
during the pulse; this feature of X-,Bgal decay curves was referred
to as a "zero-point" effect (18). The use of UPR-based constructs
(Fig. 1) instead of the earlier, reference-lacking test proteins
increased the accuracy (reproducibility) of pulse-chase assays to an
extent that the comparison of (normalized) time-zero values for
different X-4gals could be used to rank their metabolic stabilities,
yielding the N-end rule diagram of Fig. 4.
A Constant-Pulse Assay. In this assay, proteins were labeled
continuously, without a chase (Fig. 5). The ratio of 35S in
Met-,Bgal to 35S in the reference protein dha-Ub increased greatly
0
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FIG. 3. In vivo degradation of
X-j3gal test proteins. UPR-based
pulse-chase assays were carried
20 out as described in Materials and
Methods to follow the degrada-
tion of X-,Bgal test proteins (pro-
duced from dha-Ub-X-4gals) in
mouse L cells. The relative
amounts of 35S in X-,3gals, de-
fined, at each time point, as the
ratio of 35S in an X-,3gal to
dha-Ub (the reference protein),
were plotted as percentages of
the same ratio at time 0 for Met-
f3gal. Each of the decay curves
shown is the average of two in-
dependent UPR assays, whose
results differed by less than 10%.
(A) X = Met, Ala, Gly, Ile, Ser,
Thr, and Val residues. (B) X =
Met, Cys, Asp, Glu, Asn, and Gln
residues. (C) X = Met, Leu, Phe,
Trp, Tyr, His, Arg, and Lys resi-
dues. (D) X = Met, Ala, Leu, and
Arg residues, the chase times be-
ing 15, 30, and 60 min (instead of
60 and 120 min).
between 5 and 10 min of pulse, reaching a near-plateau by 20 min
(Fig. 5, open circles). The analogous ratio for Arg-,Bgal showed
similar kinetics of increase but with a lower plateau (Q35% of the
value for Met-,Bgal) (Fig. 5, closed circles). The total incorpora-
tion of 35S into proteins remained linear from 5 to at least 80 min
of pulse (Fig. 5, open squares), precluding the possibility that the
ratio curves in Fig. 5 could be caused by a decrease in the total
incorporation of 35S during the pulse.
A parsimonious interpretation of these results is that the
28-kDa dha-Ub reference moiety (seven Met residues), which
emerges from the ribosome before the 140-kDa Met-/3gal moiety
(26 Met residues) of dha-Ub-Met-,Bgal, is overrepresented as a
full-length polypeptide during the earliest times of pulse, because
it takes -0.3 min to synthesize dha-Ub but -1.5 min to synthesize
Met-4gal (assuming the rate of translation to be - 15 residues per
second under the conditions used). The contribution of this
difference in translation rates between dha-Ub and Met-f3gal to
the ratio of 35S incorporation into these proteins should progres-
sively decrease during the pulse, resulting in a nearly constant
ratio at the durations of pulse that are much longer than the
translation times, as observed (Fig. 5, open circles). The shape of
the analogous curve for Arg-,Bgal is similar to, but the plateau
value is only 35% of the value for, Met-,Bgal (Fig. 5, closed vs.
open circles), reflecting the degradation of Arg-,3gal.
DISCUSSION
In the UPR technique, a Ub moiety is placed between polypep-
tides A and B within a linear fusion. In vivo, this fusion is
cleaved, cotranslationally or nearly so, at the Ub-B junction,
yielding equimolar amounts of two separate polypeptides,
A-Ub and B (Fig. 1A). More generally, by positioning n Ub
moieties within a fusion, one can produce equimolar amounts
of n + 1 separate polypeptides in a cell. The UPR technique
has advantages over other ways of attaining this goal. For
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FIG. 4. The N-end rule in mouse L cells. The relative amounts of
X-13gal test proteins immediately after the 10-min pulse (time 0) were
determined using dha-Ub-X-,Bgal fusions (Fig. 1B) and the UPR-based
assay as described in Materials and Methods (see also the legend to Fig. 3).
The resulting values (averaged from three independent experiments) were
plotted (as percentages of the relative amount of Met-(3gal) for all
N-terminal residues in X-f3gal except the Pro residue. Standard deviations
are indicated above the bars. Single-letter abbreviations of amino acids: A,
Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu;
M, Met; N, Asn; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; Y, Tyr.
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Table 1. Parameters of X-f3gal degradation in mouse L-cells
N-terminal t0.60, t-15
residues ID10, % SD0-60, % min min
A Time(min) 5 10 20 40 80 5
X-,gal-
.."
Met
Ser
Gly
Val
Ala
Ile
Thr
His
Cys
Leu
Asp
Asn
Phe
Lys
Trp
Glu
Tyr
Gln
Arg
0
0*
0*
0.9 0.8
8.9 3.8
10.3 + 4.4
10.5 5.2
39.9 2.6
47.5 5.7
49.4 6.1
51.3 + 6.4
52.9 0.5
54.2 8.6
58.3 + 9.3
58.8 5.2
59.9 4.1
60.6 + 4.5
61.4 3.2
68.5 1.6
2.3 ± 3.3
0
21.9 ± 1.9
13.7 ± 3.0
27.7 1.4
33.7 0.2
26.5 3.8
48.4 0.6
49.6 0.6
37.2 3.1
39.6 + 3.5
44.9 + 1.7
34.7 + 4.5
45.8 4.5
43.0 2.3
43.9 2.8
34.1 ± 0.2
31.6 ± 2.9
34.8 ± 3.0
>120
>120
>120
>120
108
69
92
62
60
81
76
67
86
65
70
68
88
95
86
>120
24 B
10
32
0) 0)
0O
o 0
26
[X-,3gal]o, the "normalized" amount of an X-,Bgal at time 0 (at the end
of the 10-min pulse), was determined by dividing the mean density of
Phosphorlmager-detected pixels in the electrophoretic band of X-,3gal by
the mean density of pixels in the band of the reference protein dha-Ub
in the same lane. Initial decay of X-,Bgal at the end of the 10-min pulse
(IDI0) was calculated as follows: ID'0 = 100% {[X-,3gal]o/[Met-f3gal]o}
x 100%. Subsequent decay of X-,Bgal at 60 min of chase (SDO-60) was
calculated as follows: SD0-60 = 100% -{[X-3gal]60/[X-/3gal]o} x 100%,
where [X-I3gal]60 was the normalized amount of X-,Bgal at 60 min of chase.
t"60, the "partial" half-life of an X-I3gal between 0 and 60 min of chase,
was calculated from the values of [X-I3gal]6o and [X-I3gal]o by assuming
a first-order kinetics of degradation between these time points. Analo-
gous calculations were used to yield to-15, the partial half-life of an X-f3gal
between 0 and 15 min of chase. The zero values of ID'0 for Ser-,Bgal and
Gly-f3gal are marked by asterisks to denote the fact that the relative
amount of 35S in these X-f3gals at time 0 was marginally higher than that
in Met-f3gal (Figs. 3A and 4).
example, although cytosolic processing proteases such as viral
proteases can also generate equimolar amounts of cleavage
products from a polyprotein precursor, these proteases lack the
advantages of UBPs (i.e., their universal presence among
eukaryotes, their cotranslational cleavage kinetics, and their
lack of toxicity upon expression in organisms such as eubac-
teria that lack the Ub system). A virus-derived, peptide-size
insert was reported to function as a cotranslationally cleaving,
cis-acting protease within a polyprotein (19); this feature of the
insert may yield an analog of the UPR technique.
UPR, Pulse-Chase, and the N-End Rule. To test the utility of
UPR, we used it to determine the N-end rule in fibroblast-like
mouse L cells. Save for one residue, this in vivo-defined mamma-
lian N-end rule (Figs. 3 and 4; Table 1) is identical to the N-end
rule of rabbit reticulocytes that had been determined in ATP-
supplemented reticulocyte extract (9). The exceptional residue is
Ser, which is stabilizing in L cells (Fig. 4) but is destabilizing in
reticulocyte extract (9). N-terminal serine is often acetylated in
vivo (20); it is unknown, thus far, whether N-terminal serine of
Ser-3gal is acetylated in L cells. Because acetylation of a desta-
bilizing N-terminal residue is expected to abolish its recognition by
the N-end rule pathway (2), it remains to be seen whether the
difference in destabilizing activity between N-terminal serine in
reticulocytes (9) and in fibroblast-like L cells (Figs. 3A and 4)
defines a difference between the N-end rules of these cells or
whether it is an artifact of inefficient acetylation of N-terminal
serine in reticulocyte extract. Among destabilizing residues in the
L cell N-end rule, Ile, Ala, and Thr are the least destabilizing ones
(Fig. 3, compare A with B).
1
dha-Ub- ..;.-.- .-
a b c d e f g h i j
200
150 >x
E
0~
cn
100 ^
0
50
0
0 20 40 60 80
Time (min)
FIG. 5. The UPR-based continuous pulse assay. (A) L cells were
transfected with plasmids expressing Met-4gal (dha-Ub-Met-3gal) (lanes
a-e) or Arg-o3gal (dha-Ub-Arg-,Bgal) (lanes f-j). The cells were labeled
with [35S]methionine/cysteine for5 min (lanes a and f), 10 min (lanes b and
g), 20 min (lanes c and h), 40 min (lanes d and i), and 80 min (lanes e and
j), followed by the preparation of extracts, immunoprecipitation with
anti-ha and anti-,jgal antibodies, SDS/PAGE, and autoradiography (see
Materials and Methods). (B) The pattern inA was processed for quantita-
tion using a Phosphorlmager. 0, the ratio of Met-J3gal to dha-Ub during
the continuous pulse. 0, the same as 0 but for Arg-I3gal. Eo, total 35S in the
10% trichloroacetic acid-insoluble fraction during the continuous pulse.
In contrast to the S. cerevisiae and E. coli N-end rules, where
cysteine is a stabilizing residue (2), cysteine is clearly destabilizing
in both mouse L cells and rabbit reticulocytes (Figs. 3 and 4; ref.
12). RNAase digestion and [3H]arginine incorporation tests in
reticulocyte extract showed cysteine to be a secondary destabi-
lizing residue in reticulocytes (9) (see the Introduction for the
terminology). Whether cysteine is also a secondary destabilizing
residue in L cells remains to be determined. Unlike the other
moderately or strongly destabilizing residues (Fig. 4), cysteine can
be exposed at the N-terminus of a protein throi:lgh a cleavage by
the known Met-aminopeptidases (20). Indeed, Met-Cys-,3gal was
as metabolically unstable in L cells as Cys-43gal produced from
Ub-Cys-3gal (Fig. 3B; data not shown). Because many ORFs in
mammalianDNA encode Met-Cys at the N-termini of apparently
cytosolic proteins, it is possible that some of these ORFs encode
physiological substrates of the N-end rule pathway.
Initial and Subsequent Decay. The use of UPR confirmed and
extended the earlier evidence (6, 18) that the degradation of
engineered N-end rule substrates such as X-,Bgals is nonexponen-
tial, the metabolic stability of older X-J3gal molecules being higher
than the metabolic stability of younger ones (Fig. 3). A likely
possibility is that this increase in resistance to proteolysis is caused
by the conformational maturation of X-,Bgal in vivo, and also by
time-dependent conformational changes of the N-terminal exten-
sions in X-f3gals of this and earlier studies (Fig. 1B) (2, 6, 18).
The increased accuracy afforded by UPR underscores insuffi-
ciency of the current "half-life" terminology, because the in vivo
degradation of many proteins deviates from first-order kinetics.
This is so because a protein molecule in vivo is not a fixed structural
entity. For example, the probability of degradation of a nascent,
partially unfolded, chaperonin-associated protein should be, in
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general, different from the probability of degradation of a folded
counterpart of this protein at a later time in the same cell. In
addition, most proteins undergo covalent modifications and asso-
ciate with other molecules (including other proteins) in a cell, the
fraction of a modified or a complex-associated protein being
typically less than unity. Some of these modifications and associ-
ations are relevant to the protein's function, whereas the rest are
caused by a variety of quasi-random events that include protein
damage. Thus, an in vivo ensemble of protein molecules encoded
by one and the same ORF is inhomogeneous structurally and/or
conformationally and, therefore, may not decay exponentially. For
some short-lived proteins (e.g., S. cerevisiae Mata2p), deviations
from first-order decay (at times comparable to a half-life) appear
to be small (21). However, many other short-lived proteins,
including the engineered N-end rule substrates (Fig. 3), decay with
a pronounced nonexponential kinetics (6, 18).
Given the above, we propose a terminology for quantitative
aspects of nonexponential decay. For reasons explained below,
this terminology is introduced at first in the context of N-end rule
substrates such as X-,3gals. Specifically, Initial Decay (ID) will
denote the ratio of the amount of a labeled X-,Bgal (normalized
against a reference protein) at the end of pulse (time 0) to the
(normalized) amount of a labeled long-lived X-j,gal, such as
Met-f3gal, at the same time point (time 0) (Fig. 4). Because ID
would, in general, depend on the duration of pulse, an ID-based
terminology must invoke the pulse time explicitly. For example,
ID"' in Table 1 denotes the degradation of an X-3gal relative to
Met-fgal at the end of the 10-min pulse. The function of ID is to
convey the extent of degradation of a test protein during the pulse
(Fig. 4; Table 1).
Subsequent Decay (SD) will denote the ratio of the amount of
a labeled test protein at a given chase point to the amount of the
same labeled-protein at any earlier chase point, including the end
of pulse (time 0), with both values corrected against the amounts
of a labeled reference protein at the corresponding time points.
Thus, for every curve in Fig. 3 (A-C), one can calculate SD0-60,
SD`-'2", and SD6 -''", each of these terms addressing different
aspects of a nonexponential decay curve for an X-fgal N-end rule
substrate.
A single half-life is sufficient for describing first-order decay
(22) but is insufficient for describing other decay kinetics,
making it necessary to use different ("partial") half-life values
for different regions of a decay curve or, alternatively, to
employ the complementary ID/SD terminology. In Table 1,
the 0- and 60-min data of Fig. 3 A-C were used to calculate
ID3 and SD 0-60 for 19 different X-f3gals. Table 1 also lists the
corresponding partial half-lives, calculated for 0-60 min and
0-15 min chase times. The calculation of a partial half-life
involves the approximation that the decay of an X-,Bgal is
exponential between the relevant time points. To distinguish
between partial half-lives that describe different regions of a
decay curve, we propose a generalized half-life term, t o.-5,
where 0.5 denotes the parameter's half-life aspect and y-z
denotes the relevant time interval (from y to z min of chase).
In contrast to partial half-lives and SDs, the calculations ofwhich
are straightforward for any short-lived protein coexpressed with a
reference protein (see the legend to Table 1), the ID term for a
short-lived protein can be defined as above only in relation to
essentially the same protein that becomes metabolically stable.
This would happen, for example, if a normally short-lived protein
is expressed in a mutant cell that does not degrade the protein, or
if a degron of a short-lived protein is eliminated without altering
the number of the protein's methionines and/or other residues
that are labeled in a pulse-chase assay. The latter condition holds
in the comparisons of short-lived X-f3gals with long-lived X-,Bgals
(Fig. 4) but is more difficult to attain for many other short-lived
proteins whose degrons remain to be understood. Indeed, the
finding that a significant fraction of a short-lived X-,3gal is de-
graded during a pulse resulted from side-by-side comparisons of
relative labeling among short-lived and long-lived X-f3gals (6, 18).
Applications of UPR. One advantage of the UPR technique is
the possibility of comparing the metabolic stabilities of different
proteins using pulse data alone (Fig. 4). UPR should also allow the
determination of relative metabolic stabilities of proteins in situ. In
one example of this approach, two nearly identical, separately
quantifiable [e.g., fluorescent (23)] reporter proteins that either
lack or bear the N-degron would be coproduced in equimolar
amounts using UPR. Determining the steady-state molar ratios of
these reporters in cell extracts, cells in culture, or individual cells
in tissues of transgenic organisms should yield a direct ranking of
metabolic stabilities of N-end rule substrates bearing different
destabilizing N-terminal residues. Analogous in situ UPR assays
should be feasible with other short-lived proteins as well.
By increasing the number of Ub moieties in a UPR-based
construct, it may be possible to address the long-recognized but
poorly understood problem of cotranslational proteolysis. Con-
sider the fusion A-Ub-B-Ub-C, which is analogous to the fusion
A-Ub-B in Fig. IA but bears also the second Ub moiety and a
C-terminal reporter moiety C. In the absence of cotranslational
degradation of this fusion, the molar yield of the N-terminal
module A-Ub must be equal to the molar yield of the C-terminal
module C. Suppose that a significant fraction of B-Ub-C is
degraded processively and cotranslationally (after the cotransla-
tional cleavage by Ub-specific proteases that releases A-Ub). In
this case, the molar yield of A-Ub would be higher than that of C,
with the difference in yields being a measure of cotranslational
proteolysis. A powerful feature of this approach is that it detects
a transient kinetic effect such as cotranslational proteolysis by
measuring a "static" ratio of two quantities, the yield of A-Ub and
the yield of C, in response to alterations of the length, sequence,
and degron content of the "spacer" B-Ub. A UPR-based study of
cotranslational proteolysis is under way.
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